Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by jayjay2020on Oct 01, 2018 4:53pm
178 Views
Post# 28724736

RE:RE:Another breadcrumb?

RE:RE:Another breadcrumb?
MonstersInc wrote: Monster find!  APH is a hard one to sell since it could gap up on open 50% and take off when the press starts talking who will actually take them over.

I see APH as being the prime take over at the $5B market cap with 240,000KGs of production
I see OGI as the prime target take over at $800M market cap with a 113,000 KGs of production

And let's talk about OGI version TLRY for a second....

TONNAGE wrote: A post from someone on the APH board on yahoo.



Good morning everyone Last night I finally managed to finish reading the complete 104 page Management Information Circular that was posted to Sedar on Friday and I think I have unearthed a clue about the possible up listing; I believe @BILLS Mafia is correct and it will be to the NYSE as opposed to the Nasdaq.

In the 2018 Management Information Circular on page 96 of 104 under Exhibit "B" Board Mandate 3.0-Independance it states:

A majority of the Board will be comprised of directors who are “independent” per the standards and requirements promulgated by all governmental and regulatory bodies exercising control over Aphria as may be in effect from time to time, including Section 303A.02 of the NYSE Listed Company Manual and relevant rules of any other stock exchanges on which Aphria’s shares are listed. 

Whereas in comparison to the 2017 Management Information Circular on Page 81 of 88 Exhibit "C" Board Mandate 3.0-Independance it simply states:

The Board will be comprised of at least an equal number of independent directors as non-independent directors. 

I find it rather interesting that this has been added and I really think this could be the first step towards the news we've been waiting for and would make sense for a Diageo partnership announcement if it is in fact in the works because as @BILLS Mafia reminded me over the weekend Diageo also trades on the NYSE not the Nasdaq.....same as Canopy and Constellations Brand. Cheers everyone hopefully we start the week off with some green


Awesome find.  I think I mentioned the same a few weeks back the APH adding independant directors to meet its NYSE requirments.  Thanks to the yahoo group for proving this as the most likely scenerio. 

Bullboard Posts